Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Haleon Upgrades Richmond, Virginia, R&D Operations

01/28/2025
Consumer health company Haleon plans to upgrade its research & development operations in Richmond, Virginia.

The $54.2 million project will feature the modernization of the company's existing R&D Center of Excellence which currently provides technical functions including: consumer science, formulation development, process scale up, analytical test method development, microbiology, product stability, packaging design, and clinical supplies. 

“Today’s announcement is a significant milestone for Haleon,” said Haleon’s North America President Lisa Paley. “Our investment in the modernization of the lab space at our Research & Development facility is an investment in delivering on our mission of everyday health with humanity as well as the Richmond community. We are further excited by our partnership with the Commonwealth to co-fund a five-year paid internship program with the State of Virginia to build Richmond as a Life Science Hub and develop the future workforce. Haleon is proud to give back to the community we call home.”

To support the project the Governor approved a performance-based grant of $950,000 from the Virginia Investment Performance Grant.

“Haleon’s decision to upgrade their space here in Richmond is a vote of confidence in Virginia's life sciences ecosystem and in where they want to invest and grow globally,” noted Secretary of Commerce and Trade Caren Merrick. “This modernization will bring new research that will bridge pharmaceutical science with economic growth.”

The Virginia Economic Development Partnership (VEDP) worked with the City of Richmond and the Greater Richmond Partnership to secure the project.

“Haleon is a cornerstone of consumer healthcare R&D in Greater Richmond, and we value our longstanding relationship with the company,” added Greater Richmond Partnership President and CEO Jennifer Wakefield. “GRP is happy to have played a role in this important expansion project.”

Haleon was established in 2022 as a corporate spin-off from GSK. The company’s brands include Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins.

Exclusive Research